Activated Protein C to Treat Acute Lung Injuries

计划入组 90 人 · 首次发布于 2005 年 5 月 30 日

A Study of HS248 in Patients With Advanced Solid Tumors

计划入组 24 人 · 首次发布于 2023 年 3 月 8 日

Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam

首次发布于 2016 年 6 月 15 日

PRS 300 Series (Pieris Pharmaceuticals)

PRS-010

Pteric acid

C₁₄H₁₃N₆O₃

Pieris Pharmaceuticals

United States

Pieris Pharmaceuticals GmbH

Germany

PIERIS AUSTRALIA PTY LTD

Australia

HER2-Positive Gastric Cancer Pipeline Shows Robust Activity with 20+ Companies Developing Novel Therapies

Palvella Therapeutics Gains Analyst Attention with QTORIN Rapamycin Development for Rare Skin Diseases

Ebenbuild Secures €2.3 Million EIC Grant to Advance Digital Twin Platform for Respiratory Drug Development